Journal article
Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity
Pharmacogenomics, Vol.5(6), pp.643-655
2004
Abstract
The application of a pharmacogenetic approach to antiretroviral drug therapy represents a significant challenge, as treatment involves multiple drugs and drug classes with the potential for significant variability in drug–host, as well as drug–drug, interactions. However, despite this inherent complexity, considerable gains have been made in understanding how genetic factors influence the efficacy and toxicity of HIV therapy. In this review the available evidence regarding genetic variation in drug disposition will be examined, including the potential for relatively polymorphic drug-metabolizing enzymes (e.g., cytochrome P450 isoforms) and drug transporters (e.g., P-glycoprotein) to influence the disposition of HIV protease inhibitor and non-nucleoside reverse transcriptase inhibitor drugs. In addition, the role of genetic variation in determining the immune response to drug-specific antigens will be considered as a potentially significant determinant of susceptibility to idiosyncratic drug reactions (e.g., major histocompatibility complex alleles associated with abacavir hypersensitivity). The current and potential clinical utility of pharmacogenetic testing in HIV management will also be emphasized.
Details
- Title
- Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity
- Authors/Creators
- A.M. Martin (Author/Creator) - Royal Perth HospitalD. Nolan (Author/Creator) - Royal Perth HospitalS. Gaudieri (Author/Creator) - School of Anatomy, Physiology and Human BiologyE. Phillips (Author/Creator) - Women's College, KolkataS. Mallal (Author/Creator) - Centre for Clinical Immunology and Biomedical Statistics, Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, Western Australia. s.mallal@murdoch.edu.au
- Publication Details
- Pharmacogenomics, Vol.5(6), pp.643-655
- Publisher
- Ashley Publications Ltd.
- Identifiers
- 991005543319807891
- Murdoch Affiliation
- Centre for Clinical Immunology and Biomedical Statistics
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
35 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.66 HIV
- 1.66.1372 HIV Comorbidities
- Web Of Science research areas
- Pharmacology & Pharmacy
- ESI research areas
- Pharmacology & Toxicology